Dynavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.

About DVAX

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. 

CEO
Ryan Spencer
CEORyan Spencer
Employees
405
Employees405
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
1996
Founded1996
Employees
405
Employees405

DVAX Key Statistics

Market cap
1.23B
Market cap1.23B
Price-Earnings ratio
-19.45
Price-Earnings ratio-19.45
Dividend yield
Dividend yield
Average volume
1.38M
Average volume1.38M
High today
$10.42
High today$10.42
Low today
$10.01
Low today$10.01
Open price
$10.27
Open price$10.27
Volume
1.07M
Volume1.07M
52 Week high
$14.63
52 Week high$14.63
52 Week low
$9.22
52 Week low$9.22

DVAX News

Seeking Alpha 4d
Dynavax re-elects all board members, despite Deep Capital's push to change

Dynavax Technologies (NASDAQ:DVAX) said on Thursday that it thwarted investment firm Deep Track Capital's attempt to unseat its directors, as investors re-elect...

Dynavax re-elects all board members, despite Deep Capital's push to change

People also own

Based on the portfolios of people who own DVAX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.